105 related articles for article (PubMed ID: 30661225)
1. Meta-analysis of association between Arg326Gln (rs1503185) and Gln276Pro (rs1566734) polymorphisms of PTPRJ gene and cancer risk.
Laczmanska I; Sasiadek MM
J Appl Genet; 2019 Feb; 60(1):57-62. PubMed ID: 30661225
[TBL] [Abstract][Full Text] [Related]
2. Comments on: "Meta-analysis of association between Arg326Gln (rs1503185) and Gln276Pro (rs1566734) polymorphisms of PTPRJ gene and cancer risk".
Gholami M; M Amoli M
J Appl Genet; 2019 Nov; 60(3-4):431-433. PubMed ID: 31301025
[No Abstract] [Full Text] [Related]
3. Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers.
Mita Y; Yasuda Y; Sakai A; Yamamoto H; Toyooka S; Gunduz M; Tanabe S; Naomoto Y; Ouchida M; Shimizu K
J Cancer Res Clin Oncol; 2010 Feb; 136(2):249-59. PubMed ID: 19672627
[TBL] [Abstract][Full Text] [Related]
4. PTPRJ haplotypes and colorectal cancer risk.
Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
[TBL] [Abstract][Full Text] [Related]
5. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis.
Iuliano R; Le Pera I; Cristofaro C; Baudi F; Arturi F; Pallante P; Martelli ML; Trapasso F; Chiariotti L; Fusco A
Oncogene; 2004 Nov; 23(52):8432-8. PubMed ID: 15378013
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.
van Puijenbroek M; Dierssen JW; Stanssens P; van Eijk R; Cleton-Jansen AM; van Wezel T; Morreau H
J Mol Diagn; 2005 Nov; 7(5):623-30. PubMed ID: 16258161
[TBL] [Abstract][Full Text] [Related]
7. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR
Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091
[TBL] [Abstract][Full Text] [Related]
8. Role of PTPRJ genotype in papillary thyroid carcinoma risk.
Iuliano R; Palmieri D; He H; Iervolino A; Borbone E; Pallante P; Cianflone A; Nagy R; Alder H; Calin GA; Trapasso F; Giordano C; Croce CM; de la Chapelle A; Fusco A
Endocr Relat Cancer; 2010 Dec; 17(4):1001-6. PubMed ID: 20823296
[TBL] [Abstract][Full Text] [Related]
9. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.
Lesueur F; Pharoah PD; Laing S; Ahmed S; Jordan C; Smith PL; Luben R; Wareham NJ; Easton DF; Dunning AM; Ponder BA
Hum Mol Genet; 2005 Aug; 14(16):2349-56. PubMed ID: 16000320
[TBL] [Abstract][Full Text] [Related]
10. Tumor Suppressor PTPRJ Is a Target of miR-155 in Colorectal Cancer.
Zhang XF; Tu R; Li K; Ye P; Cui X
J Cell Biochem; 2017 Oct; 118(10):3391-3400. PubMed ID: 28316102
[TBL] [Abstract][Full Text] [Related]
11. [Colorectal cancer susceptibility genetic variants in tumor free and colorectal carcinoma bearing Hungarian population. Individual predisposition to cancer].
Szentirmay Z; Kurcsics J; Csernák E; Tándor I; Tóth E
Orv Hetil; 2018 Oct; 159(40):1614-1623. PubMed ID: 30277414
[TBL] [Abstract][Full Text] [Related]
12. No impact of PTPN22, PTPRJ and ACP1 genes polymorphisms on the risk of immune thrombocytopenia in French adult patients.
Lioger B; Rollin J; Vayne C; Perret-Gallix K; Pouplard C; Godeau B; Michel M; Gruel Y
Thromb Res; 2016 Aug; 144():76-8. PubMed ID: 27309885
[No Abstract] [Full Text] [Related]
13. LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21.
Ruivenkamp C; Hermsen M; Postma C; Klous A; Baak J; Meijer G; Demant P
Oncogene; 2003 May; 22(22):3472-4. PubMed ID: 12776199
[TBL] [Abstract][Full Text] [Related]
14. PTPRJ is downregulated in cervical squamous cell carcinoma.
Roychowdhury A; Basu M; Pal D; Dutta P; Samadder S; Mondal R; Roy AK; Roychoudhury S; Panda CK
J Genet; 2022; 101():. PubMed ID: 35791609
[TBL] [Abstract][Full Text] [Related]
15. Germline epigenetic silencing of the tumor suppressor gene PTPRJ in early-onset familial colorectal cancer.
Venkatachalam R; Ligtenberg MJ; Hoogerbrugge N; Schackert HK; Görgens H; Hahn MM; Kamping EJ; Vreede L; Hoenselaar E; van der Looij E; Goossens M; Churchman M; Carvajal-Carmona L; Tomlinson IP; de Bruijn DR; Van Kessel AG; Kuiper RP
Gastroenterology; 2010 Dec; 139(6):2221-4. PubMed ID: 21036128
[No Abstract] [Full Text] [Related]
16. Candidate genes for hereditary colorectal cancer: Mutational screening and systematic review.
Belhadj S; Terradas M; Munoz-Torres PM; Aiza G; Navarro M; Capellá G; Valle L
Hum Mutat; 2020 Sep; 41(9):1563-1576. PubMed ID: 32449991
[TBL] [Abstract][Full Text] [Related]
17. Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer.
Laczmanska I; Karpinski P; Kozlowska J; Bebenek M; Ramsey D; Sedziak T; Ziolkowski P; Sasiadek MM
Pathol Res Pract; 2014 Dec; 210(12):893-6. PubMed ID: 25169130
[TBL] [Abstract][Full Text] [Related]
18. The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma.
Casagrande S; Ruf M; Rechsteiner M; Morra L; Brun-Schmid S; von Teichman A; Krek W; Schraml P; Moch H
J Pathol; 2013 Mar; 229(4):525-34. PubMed ID: 23007793
[TBL] [Abstract][Full Text] [Related]
19. Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis.
Trapasso F; Drusco A; Costinean S; Alder H; Aqeilan RI; Iuliano R; Gaudio E; Raso C; Zanesi N; Croce CM; Fusco A
DNA Cell Biol; 2006 Jun; 25(6):376-82. PubMed ID: 16792508
[TBL] [Abstract][Full Text] [Related]
20. Loss of Protein Tyrosine Phosphatase Receptor J Expression Predicts an Aggressive Clinical Course in Patients with Esophageal Squamous Cell Carcinoma.
Qiao D; Li M; Pu J; Wang W; Zhu W; Liu H
Pathol Oncol Res; 2016 Jul; 22(3):541-7. PubMed ID: 26694178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
